Literature DB >> 2969749

Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.

C M Hekman1, D J Loskutoff.   

Abstract

The plasminogen activator inhibitor 1 (PAI-1) synthesized and released by cultured bovine aortic endothelial cells is present in conditioned medium in a latent form that can be activated by guanidine hydrochloride [Hekman, C. M., & Loskutoff, D. J. (1985) J. Biol. Chem. 260, 11581-11587]. The purified, guanidine-activated PAI-1 was shown to inhibit both plasmin and trypsin in a dose- and time-dependent manner. Second-order rate constants for these interactions were calculated to be 6.6 X 10(5) and 7.0 X 10(6) M-1 s-1 for plasmin and trypsin, respectively. Experiments were conducted to compare the inherently active and the guanidine-activated forms of PAI-1. The two active forms had similar kinetic parameters for interaction with urokinase (Kd, 0.3 pM; kassoc, 1.5 X 10(8) M-1 s-1) and were both inactivated upon treatment with acid or base and by incubation at 37 degrees C. The latent form was relatively stable when incubated under similar conditions. The decrease in PAI-1 activity upon incubation at 37 degrees C was partially restored by a second treatment with guanidine hydrochloride. However, the degree of recovery decreased as a function of incubation time at 37 degrees C. These data suggest that active and guanidine-activated PAI-1 represent a single form of PAI-1. Incubation of this form at 37 degrees C yields two distinct populations of inactive PAI-1, one capable of reactivation and another that appears to be irreversibly inactivated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969749     DOI: 10.1021/bi00408a037

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  PAI-1, fibrosis, and the elusive provisional fibrin matrix.

Authors:  D J Loskutoff; J P Quigley
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

3.  Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch.

Authors:  Stephanie Cambier; Stephanie Gline; Dezhi Mu; Rodney Collins; Jun Araya; Gregory Dolganov; Steven Einheber; Nancy Boudreau; Stephen L Nishimura
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 4.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

5.  Detection of vitronectin mRNA in tissues and cells of the mouse.

Authors:  D Seiffert; M Keeton; Y Eguchi; M Sawdey; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 6.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.